emodin has been researched along with formazans in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SH; Nan, JX; Park, EJ; Sohn, DH; Woo, SW; Zhao, YZ | 1 |
| Ge, J; Qian, J; Wang, K; Wang, X; Zou, Y | 1 |
| Gu, LQ; Wang, XD; Wu, JY | 1 |
3 other study(ies) available for emodin and formazans
| Article | Year |
|---|---|
Aloe emodin suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.
Topics: Actins; Animals; Anthraquinones; Bromodeoxyuridine; Cell Differentiation; Cell Division; Cell Survival; Collagen Type I; DNA; Dose-Response Relationship, Drug; Emodin; Enzyme Inhibitors; Fibroblasts; Formazans; Kupffer Cells; Male; Muscle, Smooth; Rats; Rats, Sprague-Dawley; Tetrazolium Salts | 2002 |
Evaluation of MTT assay for measurement of emodin-induced cytotoxicity.
Topics: Cell Line; Dose-Response Relationship, Immunologic; Emodin; Enzyme Inhibitors; Formazans; Humans; Muscle, Smooth, Vascular; Tetrazolium Salts; Thiazoles; Toxicity Tests | 2006 |
Apoptosis-inducing activity of new pyrazole emodin derivatives in human hepatocellular carcinoma HepG2 cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Emodin; Enzyme Activation; Formazans; Humans; Liver Neoplasms; Molecular Structure; Poly(ADP-ribose) Polymerases; Tetrazolium Salts; Time Factors | 2007 |